Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
---|---|
Information provided by: | National Institute on Alcohol Abuse and Alcoholism (NIAAA) |
ClinicalTrials.gov Identifier: | NCT00247585 |
The objective is to investigate residual effects of heavy drinking, with or without hangover symptoms. The primary aim is to test several hypotheses about residual effects of heavy drinking. Hypotheses about how heavy drinking affects next-day performance include direct physiological effects of alcohol, alcohol withdrawal effects, and non-ethanol effects, such as congeners, or family history of alcohol problems. The investigators will test the following hypotheses:
Condition | Intervention | Phase |
---|---|---|
Sleep Neurobehavioral Manifestations |
Drug: Ethanol (Bourbon or Vodka) |
Phase II |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Efficacy Study |
Official Title: | Hangover, Congeners, Sleep and Occupational Performance |
Estimated Enrollment: | 140 |
Study Start Date: | September 2003 |
Estimated Study Completion Date: | June 2006 |
The primary aim of the proposed study is to test several hypotheses about residual effects of heavy drinking.
Hypotheses about how heavy drinking affects next-day performance include direct physiological effects of alcohol (e.g., electrolyte imbalance, low blood sugar, sleep disturbance), alcohol withdrawal effects, acetaldehyde toxicity, and non-ethanol effects, such as congeners or family history of alcohol (Swift and Davidson, 1998).
Using a placebo-controlled randomized trial, we will dose participants with placebo or with a high or low congener alcoholic beverage (to a level of 0.10 g% BAC) the night before they perform exercises on a neurobehavioral evaluation system. We will monitor participants’ sleep to assess sleep disturbance. We will collect information on hangover symptoms the morning after dosing. We will also collect data on participants’ family history of drinking problems. We will test the following hypotheses:
We will explore whether the residual effects of heavy drinking on next-day cognitive performance are attenuated among participants positive for a family history of alcohol problems, relative to family-history-negative participants.
A secondary aim is to test the effectiveness of the Psychomotor Vigilance Test (PVT), a validated measure of fatigue, as a fitness-for-duty test. We will test whether the PVT can distinguish dosing status (alcohol or placebo) of participants at the time performance is measured the next day and the extent to which PVT measures correlate with performance scores.
Participants will be young adults ages 21-30 who are currently enrolled in an undergraduate college or university or have graduated from a college or university. Alcoholic beverages will be bourbon (high-congener) in soda or vodka (low-congener) in soda. Placebo will be tonic alone. We will use a mixed within- and between-subjects design, balancing the order of placebo and alcohol administration. Performance will be measured using a computer-based neurobehavioral evaluation system.
Ages Eligible for Study: | 21 Years to 30 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
United States, Massachusetts | |
General Clinical Research Center, Boston University School of Public Health/Boston Medical Center | |
Boston, Massachusetts, United States, 02118 |
Principal Investigator: | Jonathan Howland, PhD, MPH, MPA | Boston University |
Study ID Numbers: | NIAAAHOW12087, NIH Grant R01 AA12087-04A1 |
Study First Received: | November 1, 2005 |
Last Updated: | December 4, 2006 |
ClinicalTrials.gov Identifier: | NCT00247585 History of Changes |
Health Authority: | United States: Federal Government |
Alcohol Alcohol abuse Alcohol consumption Unhealthy alcohol use |
Residual effects Sleep Stages Respiratory Physiology |
Signs and Symptoms Neurologic Manifestations Alcohol Drinking Neurobehavioral Manifestations Ethanol |
Signs and Symptoms Nervous System Diseases Neurologic Manifestations Neurobehavioral Manifestations |